429 reports of this reaction
3.3% of all ATOVAQUONE reports
#2 most reported adverse reaction
PYREXIA is the #2 most commonly reported adverse reaction for ATOVAQUONE, manufactured by GlaxoSmithKline LLC. There are 429 FDA adverse event reports linking ATOVAQUONE to PYREXIA. This represents approximately 3.3% of all 13,088 adverse event reports for this drug.
Patients taking ATOVAQUONE who experience pyrexia should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
PYREXIA is moderately reported among ATOVAQUONE users, representing a notable but not dominant share of adverse events.
In addition to pyrexia, the following adverse reactions have been reported for ATOVAQUONE:
The following drugs have also been linked to pyrexia in FDA adverse event reports:
PYREXIA has been reported as an adverse event in 429 FDA reports for ATOVAQUONE. This does not prove causation, but indicates an association observed in post-market surveillance data.
PYREXIA accounts for approximately 3.3% of all adverse event reports for ATOVAQUONE, making it one of the most commonly reported side effect.
If you experience pyrexia while taking ATOVAQUONE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.